SCHEMBL19082289

SCHEMBL19082289

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6sc7c(ccc8c7sc7ccc9ccccc9c78)c6c5)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
F9 P00740 2/20 0.34
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
LIMK1 P53667 1/20 0.34
CYP1A1 P04798 3/20 0.33
CYP1B1 Q16678 3/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
ALOX5 P09917 2/20 0.32
S1PR4 O95977 2/20 0.32
S1PR5 Q9H228 2/20 0.32
CYP1A2 P05177 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
PTPN1 P18031 1/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082126 0.96 NQO2 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082339 0.95 F9 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082164 0.94 HSD17B1 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082287 0.93 ESR1 (0.34) ESR1ESR2F9NQO2NQO1
SCHEMBL19082294 0.93 ESR1 (0.36) ESR1ESR2F9NQO2NQO1
SCHEMBL19082147 0.92 CYP1A1 (0.38) ESR1ESR2F9NQO2NQO1
SCHEMBL19082213 0.92 LIMK1 (0.40) ESR1ESR2F9NQO2NQO1
SCHEMBL17247146 0.91 CYP1A1 (0.39) ESR1ESR2F9LIMK1CYP1A1
SCHEMBL17945329 0.91 CYP1A1 (0.39) ESR1ESR2F9LIMK1CYP1A1
SCHEMBL17931892 0.91 ESR1 (0.38) ESR1ESR2F9LIMK1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.